Direct Marketing Policy

All direct‑marketing and manuscript‑solicitation outreach undertaken on behalf of Journal of Cancer Biomoleculars and Therapeutics (JCBT, EISSN: 3060-8856) shall be appropriate, well‑targeted, and unobtrusive.

Outreach activities, including call‑for‑papers announcements, special‑issue invitations, and journal promotion, shall only target researchers whose research interests align with the journal's scope. All statements concerning journal scope, peer‑review workflow, indexing status, and publication‑related charges shall be truthful, accurate, and non‑misleading to authors and readers.

Routine operational communications for manuscript submission confirmation, reviewer invitations, and production updates are administrative notifications and are not regarded as marketing outreach. No marketing‑related communication shall imply or guarantee manuscript acceptance or favourable peer‑review results.

In the event that any recipient considers a marketing communication to be unsolicited or intrusive, the recipient may unsubscribe or opt out of future marketing contacts by notifying the editorial office. All opt‑out requests will be honoured promptly.